What is NRXPW's P/E ratio?

NRX PHARMACEUTICALS INC (NRXPW) currently trades at a P/E ratio of 1,985.03.

NRX PHARMACEUTICALS INC reports a Return on Equity (ROE) of 177.63%.

What is NRXPW's dividend yield?

NRX PHARMACEUTICALS INC offers a dividend yield of 0.00%.

What is NRXPW's Deepscope Quality Score?

Deepscope rates NRXPW's overall financial quality at 54 out of 100, based on profitability, growth, debt and earnings stability.

Is now a good time to buy NRXPW?

Deepscope's AI Timing Score for NRXPW is 1 out of 100, indicating the relative attractiveness of buying at the current price using technical and momentum signals.

NRXPW (NASDAQ) 株価分析 | NRX PHARMACEUTICALS INC

Stock Check Daily update data at 9:30 AM
(Price: 2026-05-28 | FS: 2026-03-31)

NRXPW

NRX PHARMACEUTICALS INC

US:NASDAQ STOCK News 89

USD 0.01

0.00 (0.00%) Day Change

Watchlist Portfolio Compare Chart

1,985.03

P/E

-0.03

D/E

177.6%

ROE

-206.2%

ROA

0.00%

Div Yield

12.55

PEG

NRX PHARMACEUTICALS INC
TYPE: STOCK
MARKET: NASDAQ

Compare Watchlist Myport

USD 0.01 Price 0.00 (0.00%) Day Change	NEWS SCORE: 89

NRXPW, ファンダメンタルスコアはnot quite good ( ファンダメンタル = 54) そしてテクニカルスコアは ...(Sign In to See)...

Loading chart...

54 QUALITY

Signal: UNDERPERFORM

Signal Description: Company financial health is Not Good

Reason: P/Eが高い。割高銘柄。
ROAが低い
ROEの伸びが低い
ROAがROEに比べて低い
NPMが低い
NPMの伸びが低い
NPMの伸びが低い

88 Sign in

TIMING

Signal: OUTPERFORM

Signal Descri...: Good

Reason: Lorem ipsum dolor sit amet

Unlock timing signals and detailed reasons

In details, quality factors are not good , financial health is not good , and ability to make profit is not quite good , ...

Deepscope 分析

48%

In Recommendations?	Not in any sections
Select Rate	0.00 From 30 days period
Watch Rate	0.00 From 30 days period
News Score	89
Magic Formula Rank by ROA	N/A
Magic Formula Rank by ROE	N/A
Magic Formula Rank by ROIC	N/A
Price	0.01
PBV / Sector	-51.72 / N/A
Earning Per Share	N/A

PE / Sector	1,985.03 / N/A GREAT
PEG or PE/Growth / Sector	12.55 / N/A
Average 1M Daily Value	311.560355000000
Average 1W Daily Value	123.242800000000

Timing Factors

71%

MACD	SIGN IN
MACD Signal	SIGN IN
MACD Divergence	SIGN IN
RSI	SIGN IN
Stochastic Oscillator K	SIGN IN
Stochastic Oscillator D	SIGN IN
ADX	SIGN IN
Avg 5 day Timing Score	SIGN IN

Financial Health

45%

DE / Sector	SIGN IN
DE Average / Sector	SIGN IN
DE Change Average (%) / Sector	SIGN IN
Current Ratio / Sector	SIGN IN
Current Ratio Average / Sector	SIGN IN
Current Ratio Change Average (%) / Sector	SIGN IN
Quick Ratio / Sector	SIGN IN
Quick Ratio Average / Sector	SIGN IN
Quick Ratio Change Average (%) / Sector	SIGN IN
FCF/Share / Sector	SIGN IN
FCF/Share Average / Sector	SIGN IN
FCF/Share Change Average (%) / Sector	SIGN IN

ポイントになる統計

52%

GPM (%) / Sector	SIGN IN
GPM Average (%) / Sector	SIGN IN
GPM Change Average (%) / Sector	SIGN IN
OPM (%) / Sector	SIGN IN
OPM Average (%) / Sector	SIGN IN
OPM Change Average (%) / Sector	SIGN IN
NPM (%) / Sector	-1,070.26 / N/A
NPM Average (%) / Sector	-1,703.37 / N/A
NPM Change Average (%) / Sector	N/A / N/A
Asset Turnover / Sector	SIGN IN
Asset Turnover Average / Sector	SIGN IN
Asset Turnover Change Average (%) / Sector	SIGN IN
ROA (%) / Sector	-206.17 / N/A
ROA Average (%) / Sector	-336.29 / N/A
ROA Change Average (%) / Sector	40.01 / N/A GREAT
ROE (%) / Sector	177.63 / N/A GREAT
ROE Average (%) / Sector	37.16 / N/A GREAT
ROE Change Average (%) / Sector	-35.22 / N/A
ROIC (%) / Sector	SIGN IN
ROIC Average (%) / Sector	SIGN IN
ROIC Change Average (%) / Sector	SIGN IN

配当

Dividend (%) / Sector	N/A / N/A
Dividend Average (%) / Sector	N/A / N/A
Dividend Change Average (%) / Sector	N/A / N/A

登録情報

Analyze Date	2026-06-10 09:43:46
Symbol	NRXPW
Name	NRX PHARMACEUTICALS INC
Sector
Market	NASDAQ
Listed Shares	0.00
Par Value	N/A
Calculated From	Quarter
Sign	N/A
Market Cap (M.USD) / Sector Average	714.61 / N/A

ニュース

Estimation Consensus	See at WSJ.com
Full details	See at WSJ.com
Chart	See in Chart feature
News	See at Yahoo Finance

Address: 1201 N. Market Street, Wilmington, DE, United States, 19801

Phone: 484 254 6134

Website: https://www.nrxpharma.com

Sector: -

Description: NRx Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, develops therapeutics for the treatment of central nervous system disorders comprising suicidal depression, post-traumatic stress disorder (PTSD), and schizophrenia in the United States. It operates through NRx and Dura segments. The company develops NRX-101, an oral fixed-dose combination of D-cycloserine (DCS) and lurasidone in Phase 2/3 clinical testing for bipolar depression with sub-acute ideation and behavior; NRX-100, a preservative-free formulation of ketamine for intravenous infusion and for the treatment of suicidal depression; and KETAFREE, a generic preservative-free formulation of ketamine. It also provides precision-based interventional psychiatry services to patients with treatment-resistant depression and PTSD using a combination of neuroplastic drugs, transcranial magnetic stimulation (TMS), digital therapeutics, and hyperbaric therapy; ketamine infusion therapy; stellate ganglion blocks; Spravato administration; psychotherapy; and medication management. The company has a development and license agreement with Glytech LLC. NRx Pharmaceuticals, Inc. was founded in 2015 and is headquartered in Wilmington, Delaware.